This summary was created by AI, based on 6 opinions in the last 12 months.
E.L.F. Beauty's recent financial performance indicates mixed results, with an earnings per share (EPS) of 74 cents falling short of estimates and revenue of $355 million surpassing expectations. The company's revenue guidance for fiscal 2025 was slightly reduced due to weaker demand earlier in the year, marking a deceleration in growth projected at 27-28%, the slowest in three years. Increased tariffs on imports from China and challenges within the cosmetics sector, marked by heavy short selling, add layers of risk to its outlook. Despite a relatively fair valuation compared to its historical range, experts suggest caution in entering this stock, particularly in a currently weak market for beauty products.
Is not comfortable that company sources its products from China at this time, given Trump's new tariffs.
He's long liked this growth story in consumer products. They didn't raise guidance enough, so shares plunged 14%.
Shares are down because they are heavily shorted, Estee Lauder and Ulta have been weak too. ELF is the best in a weak sector.
ELF is trading at 42.7x Forward P/E, and the growth over the next few years is expected to be solid, above 15%. In the last five years, ELF’s valuation has ranged from a 26.5x forward P/E to as high as 52.7x. We think the current valuation is fair, but we would not consider it to be an aggressive buy yet.
Unlock Premium - Try 5i Free
One of the most-shortest stocks; anything bad that happens in the cosmetics group and this gets punished. Buy in the first 14 points down or wait till Thursday.
Low cost makeup provider. Success in copying popular brands and selling on Tiktok/eCommerce. Questions on sharp rise in performance (very competitive in retail space), and whether it is sustainable. Cheap knock off products are difficult to sustain. Unsure on future of business.
A quality growth name. Take profits if this doubles, then take more profits if it doubles again. He prefers to hold onto great growth companies.
#1 in cosmetics, getting stronger in this ranking. ELF is a long-time favourite of his.
Discount makeup brand. Moving well, #3 in the US. Market share hovering around 10%. Makeup sales tend to hold up in a recession. Usually beats on earnings. Target price of $145, so potentially 20% upside. Growth in earnings and sales. Raised guidance. A meaningful opportunity. Likes the business model.
Last Wednesday they posted a monster 25 cent earnings beat and more than doubled expected earnings estimate.
e.l.f. Beauty is a American stock, trading under the symbol ELF-N on the New York Stock Exchange (ELF). It is usually referred to as NYSE:ELF or ELF-N
In the last year, 5 stock analysts published opinions about ELF-N. 2 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for e.l.f. Beauty.
e.l.f. Beauty was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for e.l.f. Beauty.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
5 stock analysts on Stockchase covered e.l.f. Beauty In the last year. It is a trending stock that is worth watching.
On 2025-02-20, e.l.f. Beauty (ELF-N) stock closed at a price of $71.11.
EPS of 74c missed estimates of 77c. Revenue of $355M beat estimates of $331M. EBITDA of $68M missed estimates by 7%. E.L.F. Beauty's slightly reduced sales outlook for fiscal 2025 reflects softer-than-expected January demand, demonstrating that the cosmetics and skin-care maker isn't immune to broader trends. The midpoint of guidance is still 5% above initial projections, as sales proved better than anticipated through 3Q, despite tough comparisons. The revised projection of $1.30-$1.31 billion in annual sales suggests a deceleration in growth to 27-28% for 2025, a three-year low. Slowing could extend into 2026 as consumers remain selective and beauty demand has yet to rebound, though store and shelf-expansion may provide an offset. Ebitda margin appears poised to be flat to slightly lower vs. fiscal 2024. Increased tariffs on imports from China could add pressure in 2026. The key word here is 'deceleration'. That, combined 26X earnings valuation and with negative stock momentum, compels us to sit this one out for a while.
Unlock Premium - Try 5i Free